Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 5—May 2003

Research

Pandemic Influenza and Healthcare Demand in the Netherlands: Scenario Analysis

Marianne L.L. van Genugten*Comments to Author , Marie-Louise A. Heijnen*, and Johannes C. Jager*
Author affiliations: *National Institute for Public Health and the Environment, Bilthoven, the Netherlands

Main Article

Table 7

Hospitalizations and deaths for alternative influenza vaccine efficacya

Scenario No. of hospitalizations
No. of deaths
Base case Vaccine efficacy
Base case Vaccine efficacy
All age groups equal to 80%b Age groups <64 y = 40%; for >65 = 30%c All age groups equal to 80% Age groups <64 y = 40%; for >65 y = 30%c
Nonintervention
10,186
10,186
10,186
4,040
4,040
4,040
Influenza vaccination






Total population
3,847
2,037
6,866
1,738
808
2,811
Risk groups 3,968 2,158 6,926 1,789 859 2,837

aSee Table 1.
bMinimum variant based on Meltzer et al. (9).
cMaximum variant assumes 80% efficacy for all ages.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO